Back to Browse Journals » Patient Preference and Adherence » Volume 2

Clopidogrel-taking behavior by drug-eluting stent patients: Discontinuers versus continuers

Authors Carole Decker, Linda Garavalia, Brian Garavalia, John A Spertus

Published Date June 2008 Volume 2008:2 Pages 167—175

DOI http://dx.doi.org/10.2147/PPA.S3443

Published 3 June 2008

Carole Decker1, Linda Garavalia2, Brian Garavalia1, John A Spertus1

1Mid America Heart Institute, Saint Luke’s Hospital, Kansas City, MO, USA; 2Department of Psychology, University of Missouri, Kansas City, MO, USA

Background: Each day, patients make choices whether or not to take their prescribed medications. Previous research has shown that 1 in 7 myocardial infarction (MI) patients discontinued thienopyridines within 1 month of receiving a drug-eluting stent (DES) with serious consequences. This qualitative research study explored in depth the clopidogrel-taking behavior among DES-treated patients who quit taking clopidogrel 1 month after treatment and those who continued therapy.

Methods: Sequential patients from a prospective MI registry who reported discontinuing clopidogrel within 30 days of DES treatment (N = 11) were matched with continuers (N = 11). Both groups underwent detailed qualitative phone interviews. Coding and thematic representation using directed qualitative content analysis by 3 PhD researchers was done.

Results: Patients were 41–77 years old and the majority was Caucasian and male. Multiple barriers were described by discontinuers that were not reported by continuers. The most frequently cited barrier was misunderstanding the intended duration of treatment. Discontinuers also described system weaknesses that contributed to early discontinuance such as gaps in the transition to primary care.

Conclusions: While premature discontinuation of a prescribed therapy is viewed by clinicians as a willful disregard for medical advice, early stopping of clopidogrel is influenced greatly by processes of care and system issues.

Keywords: medication discontinuance, drug-eluting stent post-care, myocardial infarction

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Other article by this author:

Exploring barriers to optimal anticoagulation for atrial fibrillation: interviews with clinicians

Decker C, Garavalia L, Garavalia B, Simon T, Loeb M, Spertus J, Daniel WC

Journal of Multidisciplinary Healthcare 2012, 5:129-135

Published Date: 13 June 2012

Readers of this article also read:

Novel PLGA-based nanoparticles for the oral delivery of insulin

Malathi S, Nandhakumar P, Pandiyan V, Webster TJ, Balasubramanian S

International Journal of Nanomedicine 2015, 10:2207-2218

Published Date: 19 March 2015

Adaption and validation of the Safety Attitudes Questionnaire for the Danish hospital setting

Kristensen S, Sabroe S, Bartels P, Mainz J, Christensen KB

Clinical Epidemiology 2015, 7:149-160

Published Date: 2 February 2015

Cytotoxicity of graphene oxide and graphene oxide loaded with doxorubicin on human multiple myeloma cells

Wu S, Zhao X, Cui Z, Zhao C, Wang Y, Du L, Li Y

International Journal of Nanomedicine 2014, 9:1413-1421

Published Date: 14 March 2014

Digital analysis of flap parameter accuracy and objective assessment of opaque bubble layer in femtosecond laser-assisted LASIK: a novel technique

Kanellopoulos AJ, Asimellis G

Clinical Ophthalmology 2013, 7:343-351

Published Date: 15 February 2013

Comparison of the effect between pegaptanib and ranibizumab on exudative age-related macular degeneration with small lesion size

Nishimura Y, Taguchi M, Nagai T, Fujihara M, Honda S, Uenishi M

Clinical Ophthalmology 2012, 6:365-368

Published Date: 6 March 2012

Metabolic pathway and distribution of superparamagnetic iron oxide nanoparticles: in vivo study

Schlachter EK, Widmer HR, Bregy A, Lönnfors-Weitzel T, Vajtai I, Corazza N, Bernau VJP, Weitzel T, Mordasini P, Slotboom J, Herrmann G, Bogni S, Hofmann H, Frenz M, Reinert M

International Journal of Nanomedicine 2011, 6:1793-1800

Published Date: 26 August 2011

Effect of surfactant and surfactant blends on pseudoternary phase diagram behavior of newly synthesized palm kernel oil esters

Mahdi ES, Sakeena MH, Abdulkarim MF, Abdullah GZ, Sattar MA, Noor AM

Drug Design, Development and Therapy 2011, 5:311-323

Published Date: 1 June 2011

Atorvastatin in stroke: a review of SPARCL and subgroup analysis

Branko N Huisa, Andrew B Stemer, Justin A Zivin

Vascular Health and Risk Management 2010, 6:229-236

Published Date: 30 March 2010

Current and future approaches in the prevention and treatment of diabetic retinopathy

Louis K Chang, David Sarraf

Clinical Ophthalmology 2008, 2:425-433

Published Date: 30 June 2008